Evidence map›Paper›PMID 35121983›Full record

ArticleNature cancer2020

Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects.

Tomo Osako, Hakwoo Lee, Gulisa Turashvili, Derek Chiu, Steven McKinney, Stacey E P Joosten, Darcy Wilkinson, Torsten O Nielsen, Wilbert Zwart, Joanne T Emerman and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Multiomics of Aging and Aging-Related Diseases.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Breast-Specific Molecular Clocks Comprised ofCancer prevention research (Philadelphia, Pa.) · 2021
    Article
  9. Steroid Ligands, the Forgotten Triggers of Nuclear Receptor Action; Implications for Acquired Resistance to Endocrine Therapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  10. Article
  11. Integration of Proteomics and Other Omics Data.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Tomo Osako *Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0000-0001-9250-4035
Hakwoo Lee *Department of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
Gulisa TurashviliDepartment of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
Derek ChiuDepartment of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.
Steven McKinneyDepartment of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0000-0002-1611-0867
Stacey E P JoostenDivision of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Darcy WilkinsonDepartment of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.
Torsten O NielsenDepartment of Pathology and Laboratory Medicine, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0000-0003-3769-2517
Wilbert ZwartDivision of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Joanne T EmermanDepartment of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Connie J EavesDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID http://orcid.org/0000-0002-3452-1926
Carlos CaldasCRUK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-3547-1489
Samuel AparicioDepartment of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada. saparicio@bccrc.ca.ORCID http://orcid.org/0000-0002-0487-9599
University of British Columbia · CATerry Fox Research Institute · CAThe Netherlands Cancer Institute · NLBC Cancer Agency · CAMount Sinai Hospital · CAUniversity of Cambridge · GB

Funding

CIHR 148429
6 · The paper itself

Abstract

The magnitude and scope of intrinsic age-correlated and host endocrine age-correlated gene expression in breast cancer is not well understood. From age-correlated gene expression in 3,071 breast cancer transcriptomes and epithelial protein expression of 42 markers in 5,001 breast cancers and 537 normal breast tissues, we identified a majority of age-correlated genes as putatively regulated by age-dependent estrogen signaling. Surprisingly, these included genes encoding the chromatin modifier EZH2 (which had a negative age correlation) and associated H3K27me3 (which had an inverse, positive age correlation). Among The Cancer Genome Atlas lung, thyroid, kidney and prostate transcriptomes, the largest overlap with breast cancer in age-correlated transcripts was lung cancer, for which about one-third of overlapping age-correlated transcripts appeared to be estrogen regulated. Age-quartile-stratified outcomes analysis of 3,500 breast cancers using EZH2, H3K27me3, FOXA1 and BCL2 proteins revealed distinct age-related prognostic significance. Age correlation in gene expression may thus be an important factor in ER, EZH2, H3K27me3 and other biomarker assessment and treatment strategies.

Indexed as

Breast NeoplasmsBreastEstrogensHistonesHumansMalePrognosisEstrogensHistones

Identifiers

PMID35121983
OpenAlexW3022355301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.